These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 7538542)

  • 1. A monoclonal antibody that blocks the complement regulatory activity of guinea pig erythrocytes and characterization of the antigen involved as guinea pig decay-accelerating factor.
    Okada N; Tanaka H; Takizawa H; Okada H
    J Immunol; 1995 Jun; 154(11):6103-11. PubMed ID: 7538542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surface modulation of classical pathway activation: C2 and C3 convertase formation and regulation on sheep, guinea pig, and human erythrocytes.
    Brown EJ; Ramsey J; Hammer CH; Frank MM
    J Immunol; 1983 Jul; 131(1):403-8. PubMed ID: 6602833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell-activating monoclonal antibodies, reacting with both leukocytes and erythrocytes, recognize the guinea pig Thy-1 differentiation antigen: characterization and cloning of guinea pig CD90.
    Schäfer H; Bartels T; Hahn G; Otto A; Burger R
    Cell Immunol; 1999 Nov; 197(2):116-28. PubMed ID: 10607429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification and characterization of the pig analogue of human membrane cofactor protein (CD46/MCP).
    van den Berg CW; Pérez de la Lastra JM; Llanes D; Morgan BP
    J Immunol; 1997 Feb; 158(4):1703-9. PubMed ID: 9029106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression and function of CD59 on colonic adenocarcinoma cells.
    Bjørge L; Vedeler CA; Ulvestad E; Matre R
    Eur J Immunol; 1994 Jul; 24(7):1597-603. PubMed ID: 7517877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of 1F5 antigen that prevents complement attack on homologous cell membranes.
    Harada R; Okada N; Fujita T; Okada H
    J Immunol; 1990 Mar; 144(5):1823-8. PubMed ID: 2307842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of DAF-2, a high molecular weight form of decay-accelerating factor (DAF; CD55), as a covalently cross-linked dimer of DAF-1.
    Nickells MW; Alvarez JI; Lublin DM; Atkinson JP
    J Immunol; 1994 Jan; 152(2):676-85. PubMed ID: 7506731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sheep analogue of human CD59: purification and characterization of its complement inhibitory activity.
    van den Berg CW; Harrison RA; Morgan BP
    Immunology; 1993 Mar; 78(3):349-57. PubMed ID: 7682985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Murine membrane inhibitor of complement which accelerates decay of human C3 convertase.
    Kameyoshi Y; Matsushita M; Okada H
    Immunology; 1989 Dec; 68(4):439-44. PubMed ID: 2481641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M
    Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
    Houle JJ; Hoffmann EM
    J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies capable of causing hemolysis of neuraminidase-treated human erythrocytes by homologous complement.
    Okada N; Harada R; Fujita T; Okada H
    J Immunol; 1989 Oct; 143(7):2262-6. PubMed ID: 2476502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular cloning of guinea pig membrane cofactor protein: preferential expression in testis.
    Hosokawa M; Nonaka M; Okada N; Nonaka M; Okada H
    J Immunol; 1996 Dec; 157(11):4946-52. PubMed ID: 8943400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.
    Nicholson-Weller A; Burge J; Austen KF
    J Immunol; 1981 Nov; 127(5):2035-9. PubMed ID: 6913607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple isoforms of guinea pig decay-accelerating factor (DAF) generated by alternative splicing.
    Nonaka M; Miwa T; Okada N; Nonaka M; Okada H
    J Immunol; 1995 Sep; 155(6):3037-48. PubMed ID: 7545710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells.
    Hakulinen J; Meri S
    Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of TraT protein, an anticomplementary protein produced in Escherichia coli by R100 factor, in serum resistance.
    Pramoonjago P; Kaneko M; Kinoshita T; Ohtsubo E; Takeda J; Hong KS; Inagi R; Inoue K
    J Immunol; 1992 Feb; 148(3):827-36. PubMed ID: 1730875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human recombinant soluble decay accelerating factor inhibits complement activation in vitro and in vivo.
    Moran P; Beasley H; Gorrell A; Martin E; Gribling P; Fuchs H; Gillett N; Burton LE; Caras IW
    J Immunol; 1992 Sep; 149(5):1736-43. PubMed ID: 1380537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptors on guinea-pig erythrocytes specific for cell-bound fourth component of human complement (C4).
    Wilson AB; Prichard-Thomas S; Lachmann PJ; Coombs RR
    Immunology; 1980 Feb; 39(2):195-202. PubMed ID: 7380467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a C4b binding site on the C2b domain of C2.
    Oglesby TJ; Accavitti MA; Volanakis JE
    J Immunol; 1988 Aug; 141(3):926-31. PubMed ID: 3397535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.